Search alternatives:
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
reported disease » related disease (Expand Search), related diseases (Expand Search), reported cases (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
event decrease » cement decreases (Expand Search), point decrease (Expand Search), levels decreased (Expand Search)
Showing 1 - 20 results of 10,866 for search '(( significant event decrease ) OR ( significantly ((reported disease) OR (greater decrease)) ))', query time: 0.73s Refine Results
  1. 1
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Relationship between Hot Surface Temperature and Ignition Event.

    Relationship between Hot Surface Temperature and Ignition Event. by Lei Bai (631944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    STORMS microbiome reporting checklist.

    STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    Basic information and patient characteristics according to the report.

    Basic information and patient characteristics according to the report. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Signal strength of reports of finasteride administration at the SOC level.

    Signal strength of reports of finasteride administration at the SOC level. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Signal strength of reports of finasteride administration at the SOC level

    Signal strength of reports of finasteride administration at the SOC level by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Signal strength of reports of finasteride administration in female at the PT level.

    Signal strength of reports of finasteride administration in female at the PT level. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Signal strength of reports of finasteride administration in male at the PT level.

    Signal strength of reports of finasteride administration in male at the PT level. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Signal strength of reports of finasteride administration at the PT level (age < 18).

    Signal strength of reports of finasteride administration at the PT level (age < 18). by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Signal strength of reports of finasteride administration at the PT level (age>=65).

    Signal strength of reports of finasteride administration at the PT level (age>=65). by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Number of adverse reaction case reports of finasteride administration at the PT level.

    Number of adverse reaction case reports of finasteride administration at the PT level. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Signal strength of reports of finasteride administration at the preferred term level in the FAERS database.

    Signal strength of reports of finasteride administration at the preferred term level in the FAERS database. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Signal strength of reports of finasteride administration at the PT level (age = 18-65).

    Signal strength of reports of finasteride administration at the PT level (age = 18-65). by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Clinical characteristics of reports with finasteride as the primary suspected drug from the FAERS database.

    Clinical characteristics of reports with finasteride as the primary suspected drug from the FAERS database. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year.

    Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year. by Erfan Tasdighi (9144667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Baseline characteristics across conventional cigarette use status.

    Baseline characteristics across conventional cigarette use status. by Erfan Tasdighi (9144667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes.

    Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Association between pack years of smoking and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline analysis.

    Association between pack years of smoking and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline analysis. by Erfan Tasdighi (9144667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    CVD and mortality outcomes hazard ratio (HR) by years since quit smoking among former smokers compared with current and never smokers.

    CVD and mortality outcomes hazard ratio (HR) by years since quit smoking among former smokers compared with current and never smokers. by Erfan Tasdighi (9144667)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Cessation duration and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation.

    Cessation duration and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline model evaluation. by Erfan Tasdighi (9144667)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: